ADAM15 and colon carcinoma: Interestingly, in a study by Toquet et al., ADAM15 expression was significantly downregulated in poorly differentiated colon carcinomas, and ADAM15-positive patients had a shorter OS than ADAM15-negative patients (P = 0.03) [62].